ArticleThe Journal of clinical investigation2026

Targeting CIC::DUX4 sarcoma with Minnelide in a dual recombinase-initiated genetically engineered mouse model.

MaKenna R Browne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.